Synthetic analogues of β-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3869-3876

  Dromer, Françoise ^a   Chevalier, Reynald ^b   Sendid, Boualem ^c   Improvisi, Luce ^a   Jouault, Thierry ^c   Robert, Raymond ^d   Mallet, Jean Maurice ^b   Poulain, Daniel ^c  

^a INSTITUT PASTEUR   (France)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c INSERM   (France)

^d UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,2 OLIGOMANNOSIDE; GALECTIN 3; LECTIN; MANNOSIDE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; MANNOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE;

ANTIGENICITY; ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; COLONY FORMING UNIT; ERADICATION THERAPY; FECES CULTURE; HOST PATHOGEN INTERACTION; INTESTINE INFECTION; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; YEAST COLONIZATION; ANIMAL; DRUG EFFECT; INTESTINE; METABOLISM; MOUSE; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; INTESTINES; MICE; OLIGOSACCHARIDES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036895520     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3869-3876.2002     Document Type: Article

References (54)

1. Anonymous. Nov. 23 1999. Oligomannosides de synthèse. Leur préparation et leur utilisation à la détection d'anticorps et à la prévention d'infections. European patent 99/14747.
2. Banarjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, W. J. Martone, and the National Nosocomial Infections Surveillance System. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91(Suppl. 3B):86S-89S.
3. Borg-Von Zepelin, M., and V. Gruness. 1993. Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238. J. Med. Vet. Mycol. 31:1-15.
4. Calderone, R., and W. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9:327-335.
5. Cameron, B., and L. Douglas. 1996. Blood group glycolopids as epithelial cell receptors for Candida albicans. Infect. Immun. 64:891-896.
6. Cassone, A., A. Torosantucci, M. Boccanera, G. Pellegrini, C. Palma, and F. Malavasi. 1988. Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J. Med. Microbiol. 27:233-238.
7. Chaffin, W. L., J. L. Lopez-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez. 1998. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
8. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin. Infect. Dis. 22(Suppl. 2):S73-S88.
9. Cole, G. T., K. T. Lynn, K. R. Seshan, and L. M. Pope. 1989. Gastrointestinal and systemic candidosis in immunocompromised mice. J. Med. Vet. Mycol. 27:363-380.
10. Cooper, D. N., and S. H. Barondes. 1999. God must love galectins; he made so many of them. Glycobiology 9:979-984.
11. Crich, D., and S. Sun. 1997. Direct synthesis of β-mannopyranosides by sulfoxide method. J. Org. Chem. 62:1198-1199.
12. Edwards, J. E. J., G. P. Bodey, R. A. Bowden, T. Büchner, B. E. de Pauw, S. G. Filler, M. A. Ghannoun, M. Glauser, R. Herbrecht, C. A. Kauffman, S. Kohno, P. Martino, F. Meunier, T. Mori, M. A. Pfaller, J. H. Rex, T. R. Rogers, R. H. Rubin, J. Solomkin, C. Viscoli, T. J. Walsh, and M. White. 1997. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin. Infect. Dis. 25:43-59.
13. Faille, C., J. C. Michalski, G. Strecker, D. W. Mackenzie, D. Camus, and D. Poulain. 1990. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Infect. Immun. 58:3537-3544.
14. Field, L. H., L. M. Pope, G. T. Cole, M. N. Guentel, and L. J. Berry. 1991. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Infect. Immun. 31:783-791.
15. Fradin, C., T. Jouault, A. Mallet, J. M. Mallet, D. Camus, P. Sinay, and D. Poulain. 1996. Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J. Leukoe. Biol. 60:81-87.
16. Fradin, C., D. Poulain, and T. Jouault. 2000. β-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect. Immun. 68:4391-4398.
17. Fruit, J., J. C. Cailliez, F. C. Odds, and D. Poulain. 1990. Expression of an epitope by surface glycoproteins of Candida albicans. Variability among species, strains and yeast cells of the genus Candida. J. Med. Vet. Mycol. 28:241-252.
18. Gale, C. A., C. M. Bendel, M. Mcclellan, M. Hauser, J. M. Becker, J. Berman, and M. K. Hostetter. 1998. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355-1358.
19. Han, Y., T. Kanbe, R. Cherniak, and J. E. Cutler. 1997. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immun. 65:4100-4107.
20. Han, Y., R. P. Morrison, and J. E. Cutler. 1998. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66:5771-5776.
21. Herbrecht, R., S. Neuville, V. Letscher-Bru, S. Natarajan-Ame, and O. Lortholary. 2000. Fungal infections in patients with neutropenia: Challenge in prophylaxis and treatment. Drugs Aging 17:339-351.
22. Hogenauer, C., H. F. Hammer, G. J. Krejs, and E. C. Reisinger. 1998. Mechanisms and manangement of antibiotic-associated diarrhea. Clin. Infect. Dis. 27:702-710.
23. Jacquinot, P. M., Y. Plancke, B. Sendid, G. Strecker, and D. Poulain. 1998. Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species. FEMS Microbiol. Lett. 169:131-138.
24. Jouault, T., C. Fradin, P. A. Trinel, and D. Poulain. 2000. Candida albicans-derived β-1,2-linked mannooligosaccharides induce desensitization of maerophages. Infect. Immun. 68:965-968.
25. Jouault, T., G. Lepage, A. Bernigaud, P. A. Trinel, C. Fradin, J. M. Wieruszeski, G. Strecker, and D. Poulain. 1995. β-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect. Immun. 63:2378-2381.
26. Kapteyn, J. C., L. L. Hoyer, J. E. Hecht, W. H. Muller, A. Andel, A. J. Verkleij, M. Makarow, H. Van Den Ende, and F. M. Klis. 2000. The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol. Microbiol. 35:601-611.
27. Karabanis, A., C. Hill, B. Leclerc, C. Tancrede, D. Baume, and A. Andremont. 1988. Risk factors for candidemia in cancer patients: A case-control study. J. Clin. Microbiol. 26:429-432.
28. Lemieux, R. U., D. R. Bundle, and D. A. Baker. 1975. The properties of a synthetic antigen related to the human blood group Lewis a. J. Am. Chem. Soc. 97:4076-4083.
29. Li, R., and J. Cutler. 1993. Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem. 268:18293-18299.
30. Marco, F., S. R. Lockhart, M. A. Pfaller, C. Pujol, M. S. Rangel-Frausto, T. Wiblin, H. M. Blumberg, J. E. Edwards, W. Jarvis, L. Saiman, J. E. Patterson, M. G. Rinaldi, R. P. Wenzel, the NEMIS Study Group, and D. R. Soll. 1999. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J. Clin. Microbiol. 37:2817-2828.
31. Miyakawa, Y., T. Kuribayashi, K. Kagaya, M. Suzuki, T. Nakase, and Y. Fukazawa. 1992. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect. Immun. 63:2493-2499.
32. Odds, F. C. 1988. Candida and Candidosis, 2nd Ed. Bailliere Tindall, London, United Kingdom.
33. Oshitari, T., and S. Kobayashi. 1995. Preparation of 2-O-(3-O-carbamoyl-α-D-mannopyranosyl)-L-gulopyranose: Synthetic study on the sugar moiety of antitumor antibiotic bleomycin. Tetrahedron Lett. 36:1089-1092.
34. Pittet, D., M. Monod, P. M. Suter, E. Frenk, and R. Auckenthaler. 1994. Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg. 220:751-758.
35. Pope, L. M., G. T. Cole, M. N. Guentzel, and L. J. Berry. 1979. Systemic and gastrointestingal candidiasis in infant mice after intragastric challenge. Infect. Immun. 25:702-707.
36. Rangel-Frausto, S. M., T. Wiblin, H. M. Blumberg, L. Saiman, J. Patterson, M. Rinaldi, M. Pfaller, J. E. Edwards, W. Jarvis, J. Dawson, R. P. Wenzel, and the NEMIS Study Group. 1999. National Epidemiology of Mycosis Survey (NEMIS): Variation in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin. Infect. Dis. 29:253-258.
37. Reagan, D. R., M. A. Pfaller, R. J. Hollis, and R. P. Wenzel. 1990. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin. Microbiol. 28:2733-2738.
38. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filer, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
39. Rijnders, B. J., E. Van Wijngarden, C. Verwaest, and W. E. Peertermans. 2000. Saccharomyces fungemia complicating Saccharomyces bourlardii treatment in a non-immunocompromised host. Intensive Care Med. 26:825.
40. Robert, R., G. Tronchin, V. Annaix, A. Bouali, and J. M. Senet. 1989. Use of coated latex particles for identification and localisation of Candida albicans cell surface receptors and for detection of related circulating antigens and/or antibodies in patients sera and urine, p. 217-230. In G. Quash and J. Rodwell (ed.), Covalently Modified Antigens and Antibodies in Diagnosis and Therapy. Marcel Dekker, Inc., New York, N.Y.
41. Schmidt, A., and U. Geshke. 1996. Comparative virulence of Candida albicans strains in CFW1 mice and rats. Mycoses 39:157-160.
42. Sendid, B., M. Tabouret, J. L. Poirot, D. Mathieu, J. Fruit, and D. Poulain. 1999. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: Useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 37:1510-1517.
43. Shibata, N., T. Ichikawa, M. Tojo, M. Takahashi, N. Ito, Y. Okubo, and S. Suzuki. 1985. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch. Biochem. Biophys. 243:338-348.
44. Staros, J. V., R. W. Wright, and D. M. Swingle. 1986. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156:220-222.
45. Sundstrom, P. 1999. Adhesins in Candida albicans. Curr. Opin. Microbiol. 2:353-357.
46. Suzuki, S. 1997. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr. Top. Med. Mycol. 8:57-70.
47. Szurmai, Z., L. Balatoni, and A. Liptak. 1994. Synthesis of some partially substituted methyl α-D- and phenyl 1-thio-α-D-mannopyranosides for the preparation of manno-oligosaccharides. Carbohydr. Res. 254:301-309.
48. Torosantucci, A., C. Bromuro, J. M. Gomez, C. M. Ausiello, F. Urbani, and A. Cassone. 1993. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J. Infect. Dis. 168:427-435.
49. Trinel, P. A., C. Faille, P. M. Jacquinot, J. C. Cailliez, and D. Poulain. 1992. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect. Immun. 60:3845-3851.
50. Trinel, P. A., Y. Plancke, P. Gerold, T. Jouault, F. Delplace, R. T. Schwarz, G. Strecker, and D. Poulain. 1999. The Candida albicans phospholipomannan is a family of glycolipids presenting phosphoinositolmannosides with long linear chains of beta-1,2-linked mannose residues. J. Biol. Chem. 274:30520-30526.
51. Voss, A., R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J. Clin. Microbiol. 32:975-980.
52. Yamazaki, F., S. Sato, T. Nukuda, Y. Ito, and T. Ogawa. 1990. Synthesis of α-D-Manp-(1→3)[β-D-GlcpNAc-(1→4)]- [α-D-GlepNAc-(1-4)]-[α-D-Manp-(1→6)]-β-D-Manp (1→4)-β-D-GlcpNAc-(1→4)-[α-L-Fucp-(1→6)]-D-GlcpNAc, a core glycoheptaose of a bisected complex-type glycan of glycoproteins. Carbohydr. Res. 201:31-50.
53. Yu, L., K. Lee, H. Sheth, P. Lane-Bell, G. Strivastava, O. Hindsgaul, W. Paranchych, R. Hodges, and R. Irvin. 1994. Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect. Immun. 62:2843-2848.
54. Zhang, Y.-M., J.-M. Mallet, and P. Sinay. 1992. Glycosylation using a oneelectron transfer homogenous reagent: Application to an efficient synthesis of the trimannoside core of N-glycosyl proteins. Carbohydr. Res. 236:73-88.